LASA SUPERGENERICS
Back to Balance Sheet
|
LASA SUPERGENERICS Last 5 Year Total Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹151 Cr | ₹164 Cr | ₹209 Cr | ₹208 Cr | ₹229 Cr |
What is the latest Total Liabilities ratio of LASA SUPERGENERICS ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹151 Cr |
Mar2023 | ₹164 Cr |
Mar2022 | ₹209 Cr |
Mar2021 | ₹208 Cr |
Mar2020 | ₹229 Cr |
How is Total Liabilities of LASA SUPERGENERICS Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹151 Cr | -7.93 | |
Mar2023 | ₹164 Cr | -21.66 | |
Mar2022 | ₹209 Cr | 0.63 | |
Mar2021 | ₹208 Cr | -9.16 | |
Mar2020 | ₹229 Cr | - |
Compare Total Liabilities of peers of LASA SUPERGENERICS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LASA SUPERGENERICS | ₹68.1 Cr | 6% | 45.9% | -54.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹397,342.0 Cr | 3.4% | 1.3% | -11.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹164,555.0 Cr | 2.4% | 3.2% | 11.9% | Stock Analytics | |
CIPLA | ₹127,259.0 Cr | 1.8% | 1.9% | -5.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,898.0 Cr | 2.8% | -0.9% | 3.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,394.0 Cr | 1.7% | 6.2% | -0.3% | Stock Analytics |
LASA SUPERGENERICS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LASA SUPERGENERICS | 6% |
45.9% |
-54.8% |
SENSEX | 0.9% |
1.2% |
-0.4% |
You may also like the below Video Courses